R 568 hydrochlorideCat. No. 3815 |
Price and AvailabilityBy clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy. |
|
Chemical Name: 2-Chloro-N-[(1R)-1-(3-methoxyphenyl)ethyl]-benzenepropanamine hydrochloride |
Biological Activity
Positive allosteric modulator and allosteric agonist of the human calcium-sensing receptor (hCaSR). Exhibits calcimimetic activity. Has the ability to restore function to hCaSR mutants that cause familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT). Exerts a suppressive effect on parathyroid (PT) hormone secretion; inhibits PT cell proliferation in rats with renal insufficiency.Certificate of Analysis / Safety Data Sheet
References
Wada et al (1997) The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. J.Clin.Invest. 100 2977. PMID: 9399943.
Fox et al (1999) NPS R-568: a type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium. J.Pharmacol.Exp.Ther. 290 473. PMID: 10411552.
Ying Lin Lu et al (2009) Effect of the calcimimetic R-568 [3-(2-chlorophenyl)-N-((1R)-1-(3-methoxyphenyl)ethyl)-1-propanamine] on correcting inactivating mutations in the human calcium-sensing receptor. J.Pharmacol.Exp.Ther. 331 775. PMID: 19759318.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
Keywords: R 568 hydrochloride, supplier, R568, hydrochloride, HCl, allosteric, modulators, and, allosteric, agonists, calcium-sensing, recptor, hCaSR
Quick Order
Find multiple products by catalog number
New Products in this Area
Potent and selective S1P4 agonist
H2L5186303Potent and selective LPA2 receptor antagonist
MEDICA 16FFA1 (GPR40) agonist. Also inhibits ATP citrate lyase
BX 471Potent, selective CCR1 antagonist
PF 04418948Potent and selective EP2 receptor antagonist
LatanoprostFP prostaglandin receptor agonist; also exhibits agonist activity at EP1 and EP3 receptors
GRI 977143Selective LPA2 receptor non-lipid agonist
CYM 50260Potent and selective S1P4 agonist
G-36Selective GPR30 antagonist
Strontium chlorideCalcium sensing receptor (CaSR) agonist
CS 2100Selective S1P1 agonist
SMANT hydrochlorideInhibits Smoothened (Smo) accumulation
TUG 891Potent and selective GPR120 agonist
IT1t dihydrochloridePotent CXCR4 antagonist
RuBi GABA trimethylphosphineCaged GABA; inhibits neural activity
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

